These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019 [TBL] [Abstract][Full Text] [Related]
6. Predictors of hyperkalemia risk following hypertension control with aldosterone blockade. Khosla N; Kalaitzidis R; Bakris GL Am J Nephrol; 2009; 30(5):418-24. PubMed ID: 19738369 [TBL] [Abstract][Full Text] [Related]
7. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Dieterich HA; Wendt C; Saborowski F Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159 [TBL] [Abstract][Full Text] [Related]
8. The role of aldosterone in heart failure and the clinical benefits of aldosterone blockade. Dawson A; Davies JI; Struthers AD Expert Rev Cardiovasc Ther; 2004 Jan; 2(1):29-36. PubMed ID: 15038411 [TBL] [Abstract][Full Text] [Related]
9. Aldosterone receptor blockade and the role of eplerenone: evolving perspectives. Epstein M Nephrol Dial Transplant; 2003 Oct; 18(10):1984-92. PubMed ID: 13679471 [No Abstract] [Full Text] [Related]
10. Aldosterone blockade and the mineralocorticoid receptor in the management of chronic kidney disease: current concepts and emerging treatment paradigms. Shavit L; Lifschitz MD; Epstein M Kidney Int; 2012 May; 81(10):955-968. PubMed ID: 22336987 [TBL] [Abstract][Full Text] [Related]
11. Eplerenone in the treatment of chronic heart failure. Krum H; Liew D Expert Rev Cardiovasc Ther; 2004 May; 2(3):315-20. PubMed ID: 15151479 [TBL] [Abstract][Full Text] [Related]
12. The role of aldosterone receptor blockade in the management of cardiovascular disease. Liew D; Krum H Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020 [TBL] [Abstract][Full Text] [Related]
13. Blocking aldosterone in heart failure. Shafiq MM; Miller AB Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):379-85. PubMed ID: 19661156 [TBL] [Abstract][Full Text] [Related]
14. Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications. Epstein M Am J Kidney Dis; 2001 Apr; 37(4):677-88. PubMed ID: 11273866 [TBL] [Abstract][Full Text] [Related]
15. The role of aldosterone and aldosterone-receptor antagonists in heart failure. Khan NU; Movahed A Rev Cardiovasc Med; 2004; 5(2):71-81. PubMed ID: 15184841 [TBL] [Abstract][Full Text] [Related]
16. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure. Moore TD; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934 [TBL] [Abstract][Full Text] [Related]
17. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure. Bauersachs J; Fraccarollo D Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071 [TBL] [Abstract][Full Text] [Related]
18. Exciting new drugs on the horizon - eplerenone, a selective aldosterone receptor antagonist (SARA). Coats AJ Int J Cardiol; 2001 Aug; 80(1):1-4. PubMed ID: 11532539 [TBL] [Abstract][Full Text] [Related]
19. Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data. Black HR Am Heart J; 2004 Apr; 147(4):564-72. PubMed ID: 15077068 [TBL] [Abstract][Full Text] [Related]
20. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]